Clinical Trial Update: A Study to Assess Efficacy and Safety of Nasacort® Nasal Spray in Comparison With Flixonase® Nasal Spray in Adults Suffering From Perennial Allergic Rhinitis (PAR) [Phase 3]

View source ↗

Summary

Phase 3 trial comparing Nasacort nasal spray to Flixonase in adults with perennial allergic rhinitis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Perennial Allergic Rhinitis

Drugs mentioned

• Flixonase (fluticasone propionate)
• Nasacort (triamcinolone acetonide)

Snippet

Sponsor: Sanofi | Conditions: Rhinitis Allergic | Phase 3 | Status: COMPLETED